Stocks and Investing
Stocks and Investing
Thu, September 1, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, August 31, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Roger Song Maintained (ALT) at Strong Buy with Increased Target to $35 on, Aug 31st, 2022
Roger Song of Jefferies, Maintained "Altimmune, Inc." (ALT) at Strong Buy with Increased Target from $30 to $35 on, Aug 31st, 2022.
Roger has made no other calls on ALT in the last 4 months.
There are 3 other peers that have a rating on ALT. Out of the 3 peers that are also analyzing ALT, 0 agree with Roger's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Roger
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $50 on, Wednesday, August 17th, 2022
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $26 on, Friday, August 12th, 2022
- Yasmeen Rahimi of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Wednesday, May 18th, 2022
Contributing Sources